Anti-ATS9/ ADAMTS9 functional antibody

Anti-ATS9/ ADAMTS9 functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to ADAMTS9/ADAMTS9 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE0650-Ab-1/ GM-Tg-hg-SE0650-Ab-2Anti-Human ADAMTS9 monoclonal antibodyHuman
GM-Tg-rg-SE0650-Ab-1/ GM-Tg-rg-SE0650-Ab-2Anti-Rat ADAMTS9 monoclonal antibodyRat
GM-Tg-mg-SE0650-Ab-1/ GM-Tg-mg-SE0650-Ab-2Anti-Mouse ADAMTS9 monoclonal antibodyMouse
GM-Tg-cynog-SE0650-Ab-1/ GM-Tg-cynog-SE0650-Ab-2Anti-Cynomolgus/ Rhesus macaque ADAMTS9 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE0650-Ab-1/ GM-Tg-felg-SE0650-Ab-2Anti-Feline ADAMTS9 monoclonal antibodyFeline
GM-Tg-cang-SE0650-Ab-1/ GM-Tg-cang-SE0650-Ab-2Anti-Canine ADAMTS9 monoclonal antibodyCanine
GM-Tg-bovg-SE0650-Ab-1/ GM-Tg-bovg-SE0650-Ab-2Anti-Bovine ADAMTS9 monoclonal antibodyBovine
GM-Tg-equg-SE0650-Ab-1/ GM-Tg-equg-SE0650-Ab-2Anti-Equine ADAMTS9 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE0650-Ab-1/ GM-Tg-hg-SE0650-Ab-2; GM-Tg-rg-SE0650-Ab-1/ GM-Tg-rg-SE0650-Ab-2;
GM-Tg-mg-SE0650-Ab-1/ GM-Tg-mg-SE0650-Ab-2; GM-Tg-cynog-SE0650-Ab-1/ GM-Tg-cynog-SE0650-Ab-2;
GM-Tg-felg-SE0650-Ab-1/ GM-Tg-felg-SE0650-Ab-2; GM-Tg-cang-SE0650-Ab-1/ GM-Tg-cang-SE0650-Ab-2;
GM-Tg-bovg-SE0650-Ab-1/ GM-Tg-bovg-SE0650-Ab-2; GM-Tg-equg-SE0650-Ab-1/ GM-Tg-equg-SE0650-Ab-2
Products NameAnti-ADAMTS9 monoclonal antibody
Formatmab
Target NameADAMTS9
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-ADAMTS9 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE0650-Ag-1Recombinant multi-species ATS9/ ADAMTS9 protein


    Target information

    Target IDGM-SE0650
    Target NameADAMTS9
    Gene ID56999,101401,312566,698341,606847,101085359,537051,100049887
    Gene Symbol and Synonyms1810011L16Rik,8430403M15Rik,ADAMTS9,E030027K14Rik,Gsfund3,Mhdaund3,Mhdaund4,UND3,UND4
    Uniprot AccessionQ9P2N4
    Uniprot Entry NameATS9_HUMAN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseCancer
    Gene EnsemblENSG00000163638
    Target ClassificationTumor-associated antigen (TAA)

    The target: ADAMTS9, gene name: ADAMTS9, also named as . This gene encodes a member of the ADAMTS (a disintegrin and metalloproteinase with thrombospondin motifs) protein family. Members of the family share several distinct protein modules, including a propeptide region, a metalloproteinase domain, a disintegrin-like domain, and a thrombospondin type 1 (TS) motif. Individual members of this family differ in the number of C-terminal TS motifs, and some have unique C-terminal domains. Members of the ADAMTS family have been implicated in the cleavage of proteoglycans, the control of organ shape during development, and the inhibition of angiogenesis. This gene is localized to chromosome 3p14.3-p14.2, an area known to be lost in hereditary renal tumors. Alternative splicing results in multiple transcript variants encoding different isoforms that may undergo similar proteolytic processing. [provided by RefSeq, Jan 2016].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.